^
    No biomarker
    Rectal Cancer
    FOLFIRI
    Sensitive
    :
    A1
    No biomarker
    Rectal Cancer
    Mvasi (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Rectal Cancer
    irinotecan
    Sensitive
    :
    A1
    No biomarker
    Rectal Cancer
    Bevax (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Rectal Cancer
    FOLFOXIRI
    Resistant
    :
    A2
    No biomarker
    Rectal Cancer
    capecitabine
    Sensitive
    :
    A2
    No biomarker
    Rectal Cancer
    FOLFOX
    Sensitive
    :
    A2
    MSI-H/dMMR
    Rectal Cancer
    nivolumab
    Sensitive
    :
    C1
    PD-L1 expression
    Rectal Cancer
    nivolumab
    Sensitive
    :
    C3
    TMB-H
    Rectal Cancer
    nivolumab
    Sensitive
    :
    C3
    TACC3 expression
    Rectal Cancer
    5-fluorouracil
    Resistant
    :
    C3
    TACC3 expression
    Rectal Cancer
    FOLFOX
    Resistant
    :
    C3
    TACC3 expression
    Rectal Cancer
    CAPOX
    Resistant
    :
    C3
    TACC3 expression
    Rectal Cancer
    capecitabine
    Resistant
    :
    C3
    PAI1 expression
    Rectal Cancer
    AZD1208
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES